Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

BACKGROUND: Although programmed cell death 1 (PD‐1) blockade plus chemotherapy can significantly prolong the progression‐free survival (PFS) and overall survival (OS) in first‐line settings in patients with driver‐negative advanced non‐small‐cell lung cancer (NSCLC), the predictive biomarkers remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fengying, Jiang, Tao, Chen, Gongyan, Huang, Yunchao, Zhou, Jianying, Lin, Lizhu, Feng, Jifeng, Wang, Zhehai, Shu, Yongqian, Shi, Jianhua, Hu, Yi, Wang, Qiming, Cheng, Ying, Chen, Jianhua, Lin, Xiaoyan, Wang, Yongsheng, Huang, Jianan, Cui, Jiuwei, Cao, Lejie, Liu, Yunpeng, Zhang, Yiping, Pan, Yueyin, Zhao, Jun, Wang, LiPing, Chang, Jianhua, Chen, Qun, Ren, Xiubao, Zhang, Wei, Fan, Yun, He, Zhiyong, Fang, Jian, Gu, Kangsheng, Dong, Xiaorong, Zhang, Tao, Shi, Wei, Zou, Jianjun, Bai, Xuejuan, Ren, Shengxiang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759770/
https://www.ncbi.nlm.nih.gov/pubmed/36331328
http://dx.doi.org/10.1002/cac2.12383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759770/
https://www.ncbi.nlm.nih.gov/pubmed/36331328
http://dx.doi.org/10.1002/cac2.12383

Ejemplares similares